Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin®) conjugated polyethylenimine

Journal of Controlled Release

Volumn 97, Issue 2, 2004, Pages 357-369

  Chiu, Shih Jiuan ^a   Ueno, Naoto T ^b   Lee, Robert J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Drug targeting; Gene therapy; HER 2 neu; HER2 receptor; Nonviral gene transfer vectors; Polyethylenimine; Trastuzumab

Indexed keywords

BIOLOGICAL ORGANS; CELLS; GROWTH KINETICS; MONOCLONAL ANTIBODIES; ORGANIC COMPOUNDS; TUMORS;

CATIONIC POLYMERS; TUMOR-TARGETED GENE DELIVERY;

GENE TRANSFER;

POLYETHYLENEIMINE; TRASTUZUMAB;

ARTICLE; CANCER CELL; CONTROLLED STUDY; EVALUATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; DNA; DRUG CARRIERS; ELECTROPHORESIS, AGAR GEL; HUMANS; LUCIFERASES, FIREFLY; PLASMIDS; POLYETHYLENEIMINE; RECEPTOR, ERBB-2; TRANSFECTION;

EID: 2942520109     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.03.019     Document Type: Article

References (50)

1. Walther W., Stein U. Viral vectors for gene transfer - a review of their use in the treatment of human diseases. Drugs. 60:2000;249-271
2. Lasic D.D., Templeton N.S. Liposomes in gene therapy. Adv. Drug Deliv. Rev. 20:1996;221-266
3. Liu F., Huang L. Development of non-viral vectors for systemic gene delivery. J. Control. Release. 78:2002;259-266
4. Gosselin M.A., Guo W.J., Lee R.J. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12:2001;989-994
5. Guillem V.M., Tormo M., Revert F., Benet I., Garcia-Conde J., Crespo A., Alino S.F. Polyethyleneimine-based immunopolyplex for targeted gene transfer in human lymphoma cell lines. J. Gene Med. 4:2002;170-182
6. Ueno N.T., Bartholomeusz C., Xia W.Y., Anklesaria P., Bruckheimer E.M., Mebel E., Paul R., Li S., Yo G.H., Huang L., Hung M.C. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1a gene. Cancer Res. 62:2002;6712-6716
7. Guo W.J., Gosselin M.A., Lee R.J. Characterization of a novel diolein-based LPDII vector for gene delivery. J. Control. Release. 83:2002;121-132
8. Rolland A.P. From genes to gene medicines: recent advances in nonviral gene delivery. Crit. Rev. Ther. Drug Carr. Syst. 15:1998;143-198
9. Nishikawa M., Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12:2001;861-870
10. Boussif O., Zanta M.A., Behr J.P. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 3:1996;1074-1080
11. Boussif O., Lezoualch F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo-polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7297-7301
12. Remy J.S., Abdallah B., Zanta M.A., Boussif O., Behr J.P., Demeneix B. Gene transfer with lipospermines and polyethylenimines. Adv. Drug Deliv. Rev. 30:1998;85-95
13. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J. Control. Release. 60:1999;149-160
14. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., Demeneix B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum. Gene Ther. 7:1996;1947-1954
15. Goula D., Benoist C., Mantero S., Merlo G., Levi G., Demeneix B.A. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 5:1998;1291-1295
16. Goula D., Remy J.S., Erbacher P., Wasowicz M., Levi G., Abdallah B., Demeneix B.A. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 5:1998;712-717
17. Godbey W.T., Wu K.K., Mikos A.G. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res. 45:1999;268-275
18. Kichler A., Leborgne C., Coeytaux E., Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene Med. 3:2001;135-144
19. Dachs G.U., Dougherty G.J., Stratford I.J., Chaplin D.J. Targeting gene therapy to cancer: a review. Oncol. Res. 9:1997;313-325
20. Rubin I., Yarden Y. The basic biology of Her2. Ann. Oncol. 12(Suppl. 1):2001;S3-S8
21. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the her-2/neu oncogene. Science. 235:1987;177-182
22. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19:2000;3159-3167
23. Cho H.-S., Mason K., Ramyar K.X., Stanley A.M., Gabelli S.B., Denney D.W.J., Leahy D.J. Structure of the extracellular region of Her2 alone and in complex with the herceptin Fab. Nature. 421:2003;756-760
24. Park J.W., Hong K., Carter P., Asgari H., Guo L.Y., Keller G.A., Wirth C., Shalaby R., Kotts C., Wood W.I. Development of anti-p185her2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1327-1331
25. Carter P., Presta L., Gorman C.M., Ridgway J.B.B., Henner D., Wong W.L.T., Rowland A.M., Kotts C., Carver M.E., Shepard H.M. Humanization of an anti-p185her2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U. S. A. 89:1992;4285-4289
26. Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C.C., Dantis L., Sklarin N.T., Seidman A.D., Hudis C.A., Moore J., Rosen P.P., Twaddell T., Henderson I.C., Norton L. Phase II study of weekly intravenous trastuzumab (herceptin) in patients with her2/neu-overexpressing metastatic breast cancer. Semin. Oncol. 26:1999;78-83
27. Baselga J. Clinical trials of herceptin (trastuzumab). Eur. J. Cancer. 37(Suppl. 1):2001;S18-S24
28. Vogel C., Cobleigh M.A., Tripathy D., Gutheil J.C., Harris L.N., Fehrenbacher L., Slamon D.J., Murphy M., Novotny W.F., Burchmore M., Shak S., Stewart S.J. First-line, single-agent herceptin (trastuzumab) in metastatic breast cancer: a preliminary report. Eur. J. Cancer. 37:2001;S25-S29
29. Wright M., Grim J., Deshane J., Kim M., Strong T.V., Siegal G.P., Curiel D.T. An intracellular anti-ErbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbb-2. Gene Ther. 4:1997;317-322
30. SafiejkoMroczka B., Bell P.B. Bifunctional protein cross-linking reagents improve labeling of cytoskeletal proteins for qualitative and quantitative fluorescence microscopy. J. Histochem. Cytochem. 44:1996;641-656
31. Gosselin M.A., Guo W.J., Lee R.J. Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. Bioconjug. Chem. 13:2002;1044-1053
32. Rhaese S., von Briesen H., Rubsamen-Waigmann H., Kreuter J., Langer K. Human serum albumin-polyethylenimine nanoparticles for gene delivery. J. Control. Release. 92:2003;199-208
33. Lewis G.D., Figari I., Fendly B., Wong W.L., Carter P., Gorman C., Shepard H.M. Differential responses of human tumor cell lines to anti-p185her2 monoclonal antibodies. Cancer Immunol. Immunother. 37:1993;255-263
34. Park J.W., Hong K.L., Kirpotin D.B., Colbern G., Shalaby R., Baselga J., Shao Y., Nielsen U.B., Marks J.D., Moore D., Papahadjopoulos D., Benz C.C. Anti-her2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin. Cancer Res. 8:2002;1172-1181
35. Goren D., Horowitz A.T., Zalipsky S., Woodle M.C., Yarden Y., Gabizon A. Targeting of stealth liposomes to ErbB-2 (her/2) receptor: in vitro and in vivo studies. Br. J. Cancer. 74:1996;1749-1756
36. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., Wagner E. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4:1997;409-418
37. Kircheis R., Wightman L., Kursa M., Ostermann E., Wagner E. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther. 9:2002;731-735
38. Guo W.J., Lee R.J. Efficient gene delivery via non-covalent complexes of folic acid and polyethylenimine. J. Control. Release. 77:2001;131-138
39. Benns J.M., Mahato R.I., Kim S.W. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J. Control. Release. 79:2002;255-269
40. Wightman L., Kircheis R., Rossler V., Carotta S., Ruzicka R., Kursa M., Wagner E. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3:2001;362-372
41. Dauty E., Remy J.-S., Zuber G., Behr J.-P. Intracellular delivery of nanometric DNA particles via the folate receptor. Bioconjug. Chem. 13:2002;831-839
42. Silverton E.W., Navia M.A., Davies D.R. Three-dimensional structure of an intact human immunoglobulin. Proc. Natl. Acad. Sci. U. S. A. 74:1977;5140-5144
43. Oh Y.K., Suh D., Kim J.M., Choi H.G., Shih K., Ko J.J. Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther. 9:2002;1627-1632
44. Pouton C.W., Seymour L.W. Key issues in non-viral gene delivery. Adv. Drug Deliv. Rev. 46:2001;187-203
45. Davis M.E. Non-viral gene delivery systems. Curr. Opin. Biotechnol. 13:2002;128-131
46. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4607-4612
47. Ogris M., Steinlein P., Kursa M., Mechtler K., Kircheis R., Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5:1998;1425-1433
48. Ogris M., Brunner S., Schuller S., Kircheis R., Wagner E. Pegylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:1999;595-605
49. Li S., Tseng W.C., Stolz D.B., Wu S.P., Watkins S.C., Huang L. Dynamic changes in the characteristics of cationic lipid vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. 6:1999;585-594
50. Wiethoff C.M., Middaugh C.R. Barriers to nonviral gene delivery. J. Pharm. Sci. 92:2003;203-217